Annovis Bio Inc. News, Annovis Bio Inc. Quote, ANVS Quote

Annovis Bio Inc. (NY:ANVS) Delayed: 2.49 +0.01 (0.40%)

Prev. Close

$2.48

Today 6M 1Y 5Y

Open

$2.51

52 Wk High

$0.04

52 Wk Low

$0.01

Day High

$2.55

Day Low

$2.45

P/E

N/A

EPS

$-0.03

Volume

171,319

Friends, Peers and Foes (?): TRAW, NTLA, RXRX ZYME (more...)

ALERTS | RSS

Mar 3, 2026 08:00 AM Annovis Announces Two Presentations at the AD/PD™ 2026 International Conference
Feb 12, 2026 09:01 AM Form 8-K Annovis Bio, Inc. For: Feb 12
Feb 12, 2026 08:00 AM Annovis receives safety board approval for Alzheimer's drug trial
Feb 12, 2026 08:00 AM Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
Jan 28, 2026 04:29 PM Form 8-K Annovis Bio, Inc. For: Jan 28
Dec 18, 2025 04:35 PM Annovis Bio to launch extension study for Parkinson's drug buntanetap
Dec 18, 2025 04:35 PM Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
Dec 18, 2025 04:35 PM Annovis Announces Open-Label Extension Study for Parkinson's Disease Patients
Dec 16, 2025 08:00 AM Annovis to Host Corporate Update Webinar on January 28, 2026
Dec 8, 2025 08:05 PM Form 4 Annovis Bio, Inc. For: Dec 08 Filed by: Hoffman Michael B

Entities mentioned with ANVS

View All Entities